08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

Croissy-Beaubourg, June 8, 8:15am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today provides an update on its new Covid-19 test program launched in response to the…

Continue Reading 08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.

Croissy-Beaubourg, May 18, 2020, 7:30pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), specializes in in vitro diagnostics and theranostics. Regarding the new Covid-19 testing activity recently initiated, Theradiag confirms that the viremia test developed by…

Continue Reading 18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.

14/05/2020 : Combined General Meeting of May 14, 2020 Second meeting scheduled for June 25, 2020 Update on Covid-19 activities

Croissy-Beaubourg, May 14, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), which specializes in in vitro diagnostics and theranostics, today announces that its Annual General Meeting convened on May 14, 2020 could not validly…

Continue Reading 14/05/2020 : Combined General Meeting of May 14, 2020 Second meeting scheduled for June 25, 2020 Update on Covid-19 activities